Results 241 to 250 of about 212,404 (311)

Missed breast cancer:The legal factors [PDF]

, 2005
Weir, Michael
core  

Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment

VIEW, EarlyView.
Our study presents a tumour‐informed circulating tumour DNA (ctDNA) workflow designed to enhance the detection of recurrence in head and neck cancer patients, addressing key challenges such as low ctDNA tumour fractions and tumour heterogeneity. Abstract Circulating tumour DNA (ctDNA) is a promising minimally invasive biomarker for monitoring treatment
Xiaomin Huang, Paul Leo, Mhairi Clout, Lynn Fink, Jonathan Ellis, Brett G. M. Hughes, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadeera   +8 more
wiley   +1 more source

Machine learning model for fast prediction and uncertainty quantification of needle deflection during prostate biopsy. [PDF]

Med Phys
Hoffman N, Al-Zogbi L, Krieger A, Tokuda J, Moreira P, Fuge M.   +5 more
europepmc   +1 more source

Interpretations on the Diagnostic Dilemma in Thyroidology: Diffuse Large B-Cell Lymphoma of the Thyroid With Hashimoto Thyroiditis. [PDF]

Clin Case Rep
Sengul I, Sengul D.
europepmc   +1 more source

Diagnostic value and related factors of ultrasound-guided percutaneous needle biopsy in bone lesions suspicious for tumor. [PDF]

BMC Musculoskelet Disord
Xu S, Jiao G, Zhou L.
europepmc   +1 more source